Clinical Trials Browser

Phase 2 × Sorafenib × 30 days × Clear all

NCT05669339 2026-06-04

AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular